Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of Cardiomyopathies
2011
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
2017
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Sarcomeric hypertrophic cardiomyopathy: Genetic profile in a Portuguese population
2012
Early Results of Sarcomeric Gene Screening from the Egyptian National BA-HCM Program
2012
Danon’s disease as a cause of hypertrophic cardiomyopathy: a systematic survey
2004
Relevance of Lung Ultrasound in the Diagnosis of Acute Respiratory Failure*: The BLUE Protocol
2008 Standout
Relation of Electrocardiographic Patterns to Phenotypic Expression and Clinical Outcome in Hypertrophic Cardiomyopathy
2005
Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends
2009
Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
2010
Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
2013
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy
2011
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses
2003
Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement
2005
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
2006
Lamins A and C but Not Lamin B1 Regulate Nuclear Mechanics
2006
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
2001
Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up
2008
The Failing Heart — An Engine Out of Fuel
2007 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats.
1993
Wound repair and regeneration
2008 StandoutNature
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population
2003
B-type natriuretic peptide in cardiovascular disease
2003
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Inherited Cardiomyopathies
2011
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Aortic Valve Replacement
2009
Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy
2009
Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial
2014
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
2001
The Prognostic Value of Big Endothelin-1 in More Than 2,300 Patients With Heart Failure Enrolled in the Valsartan Heart Failure Trial (Val-HeFT)
2006
Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case
2004
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
2010
Statistical Models and Patient Predictors of Readmission for Heart Failure<subtitle>A Systematic Review</subtitle>
2008
Noninvasive Detection of Fibrosis Applying Contrast-Enhanced Cardiac Magnetic Resonance in Different Forms of Left Ventricular Hypertrophy
2009
Platelet Activation and Atherothrombosis
2007 Standout
Self‐Care for the Prevention and Management of Cardiovascular Disease and Stroke
2017
Outcome of Patients With Hypertrophic Cardiomyopathy and a Normal Electrocardiogram
2009
Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment
2010
Insights into genotype–phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3
2010
The “All of Us” Research Program
2019 Standout
Yield of Genetic Testing in Hypertrophic Cardiomyopathy
2005
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
2001
Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1
2010
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
2008
Aortic Regurgitation
2004
A Locus for Autosomal Dominant Mitral Valve Prolapse on Chromosome 11p15.4
2003
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation
2006
Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives
2008
Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations
2011
Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)
2011
Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia
2006
Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children
1998
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Genetic Misdiagnoses and the Potential for Health Disparities
2016
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
2010
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion
2003
Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure
1998
Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice
2011
Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy
2002
Hypertrophic Cardiomyopathy
2002 Standout
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
2004
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac β-myosin gene mutations
2003
Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy
2013
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
2010
The Hallmarks of Aging
2013 Standout
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
2010
Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
2011
Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial
2000
Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults
2008
Antithrombotic and Thrombolytic Therapy for Valvular Disease
2012
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
2009 StandoutNobel
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
1998 Standout
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the “LOWERING-IT” Trial
2010
Biomarkers in Heart Failure
2008 Standout
Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the st. jude medical prosthesis
2000
Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy
2003
Hemorrhagic Complications of Anticoagulant Treatment
2004
Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration
2007
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Progress With Genetic Cardiomyopathies
2009
Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy
2012
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children
2007
Disruption of spatiotemporal hypoxic signaling causes congenital heart disease in mice
2017
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
1998
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
New Locus for Autosomal Dominant Mitral Valve Prolapse on Chromosome 13
2005
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum
2012
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
2014
Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department with Acute Heart Failure Syndromes
2007
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Modifier genes for hypertrophic cardiomyopathy
2002
Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis
2007
Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy
2008
Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis
2013 StandoutNobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Familial Hypertrophic Cardiomyopathy
1998
Yield of Genetic Testing in Hypertrophic Cardiomyopathy
2005
Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP)
2007
Patients With Familial Hypertrophic Cardiomyopathy Caused by a Phe110Ile Missense Mutation in the Cardiac Troponin T Gene Have Variable Cardiac Morphologies and a Favorable Prognosis
1998
Polysaccharide electrospun fibers with sulfated poly(fucose) promote endothelial cell migration and VEGF-mediated angiogenesis
2014
Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly
2002
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy
2003
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation
2014
Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene
2011
Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.
1997
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, american heart association
1998
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
2020
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults
2019
Physiological Concentrations of Estradiol Attenuate Endothelin 1–Induced Coronary Vasoconstriction In Vivo
1997
Influence of β -Blockers on Mortality in Chronic Heart Failure
2000
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article*1A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography)
2003
Works of Richard Isnard being referenced
A Novel Genetic Variant in the Transcription Factor Islet-1 Exerts Gain of Function on Myocyte Enhancer Factor 2C Promoter Activity
2012
Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
1999
Acute respiratory failure in the elderly: etiology, emergency diagnosis and prognosis
2006
Variations in plasma endothelin concentrations during coronary spasm
1993
GFP-transduced CD34+ and Lin− CD34− hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct
2007
Genotype-phenotype analysis in four families with mutations in β-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy
1998
Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: A noninvasive study
1989
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy
2009
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure
2004
Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure
1996
Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathy
2005
Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure
2000
Low negative predictive value of dobutamine stress echocardiography before abdominal aortic surgery
2006
Prevalence of Memory Disorders in Ambulatory Patients Aged ≥70 Years With Chronic Heart Failure (from the EFICARE Study)
2014
Pregnancy in women with a cardiomyopathy: Outcomes and predictors from a retrospective cohort
2017
Prognostic value of plasma endothelin-1 in patients with chronic heart failure
1997
Alteration of Cardiac and Renal Functions in Transgenic Mice Overexpressing Human Mineralocorticoid Receptor
2001
Comparison of Brain Natriuretic Peptide and Probrain Natriuretic Peptide in the Diagnosis of Cardiogenic Pulmonary Edema in Patients Aged 65 and Older
2005
Identification of two novel mutations in the ventricular regulatory myosin light chain gene ( MYL2 ) associated with familial and classical forms of hypertrophic cardiomyopathy
1998
Mouse model carrying H222P- Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies
2004
Doppler Echocardiography in Familial Hypertrophic Cardiomyopathy
1995
Mesenchymal Stem Cell Delivery into Rat Infarcted Myocardium Using a Porous Polysaccharide-Based Scaffold: A Quantitative Comparison With Endocardial Injection
2011
Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey
2007
Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene
1998
The Genetic Bases of Cardiomyopathies
2006
Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with a long follow-up.
2003
Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging
2010
AREVA: Multicenter Randomized Comparison of Low-Dose Versus Standard-Dose Anticoagulation in Patients With Mechanical Prosthetic Heart Valves
1996
Atrial natriuretic peptide during water deprivation or hemorrhage in rats. Relationship with arginine vasopressin and osmolarity
1992
Hypertrophic Cardiomyopathy
2003
0203: Pregnancy in women with a cardiomyopathy: outcomes and predictors from a retrospective cohort
2016
Correlation Between Left Ventricular Hypertrophy and GAA Trinucleotide Repeat Length in Friedreich's Ataxia
1997
Diagnostic Value of Electrocardiography and Echocardiography for Familial Hypertrophic Cardiomyopathy in a Genotyped Adult Population
1997